While much experimental data shows that vaccination efficiently inhibits a subsequent challenge by a transplantable tumor, its ability to inhibit the progress of autochthonous preneoplastic lesions is virtually unknown. In this article, we show that a combined DNA and cell vaccine persistently inhibits such lesions in a murine HER-2/neu mammary carcinogenesis model. At 10 weeks of age, all of the ten mammary gland samples from HER-2/neu-transgenic mice displayed foci of hyperplasia that progressed to invasive tumors. Vaccination with plasmids coding for the transmembrane and extracellular domain of rat p185neu followed by a boost with rp185neu+ allogeneic cells secreting IFN-gamma kept 48% of mice tumor free. At 22 weeks, their mammary glands were indistinguishable from those of 10-week-old untreated mice. Furthermore, the transcription patterns of the two sets of glands coincided. Of the 12,000 genes analyzed, 17 were differentially expressed and related to the antibody response. The use of B cell knockout mice as well as the concordance of morphologic and gene expression data demonstrated that the Ab response is the main mechanism facilitating tumor growth arrest. This finding suggests that a new way can be found to secure the immunologic control of the progression of HER-2/neu preneoplastic lesions.

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions / QUAGLINO E; ROLLA S; IEZZI M; SPADARO M; MUSIANI P; DE GIOVANNI C; LOLLINI PL; LANZARDO S; FORNI G; SANGES R; CRISPI S; DE LUCA P; CALOGERO R; CAVALLO F.. - In: THE JOURNAL OF CLINICAL INVESTIGATION. - ISSN 0021-9738. - 113(2004), pp. 709-717.

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

QUAGLINO, Elena;ROLLA, SIMONA;SPADARO, Michela;LANZARDO, Stefania;FORNI, Guido;CALOGERO, Raffaele Adolfo;CAVALLO, Federica
2004

Abstract

While much experimental data shows that vaccination efficiently inhibits a subsequent challenge by a transplantable tumor, its ability to inhibit the progress of autochthonous preneoplastic lesions is virtually unknown. In this article, we show that a combined DNA and cell vaccine persistently inhibits such lesions in a murine HER-2/neu mammary carcinogenesis model. At 10 weeks of age, all of the ten mammary gland samples from HER-2/neu-transgenic mice displayed foci of hyperplasia that progressed to invasive tumors. Vaccination with plasmids coding for the transmembrane and extracellular domain of rat p185neu followed by a boost with rp185neu+ allogeneic cells secreting IFN-gamma kept 48% of mice tumor free. At 22 weeks, their mammary glands were indistinguishable from those of 10-week-old untreated mice. Furthermore, the transcription patterns of the two sets of glands coincided. Of the 12,000 genes analyzed, 17 were differentially expressed and related to the antibody response. The use of B cell knockout mice as well as the concordance of morphologic and gene expression data demonstrated that the Ab response is the main mechanism facilitating tumor growth arrest. This finding suggests that a new way can be found to secure the immunologic control of the progression of HER-2/neu preneoplastic lesions.
THE JOURNAL OF CLINICAL INVESTIGATION
113
709
717
QUAGLINO E; ROLLA S; IEZZI M; SPADARO M; MUSIANI P; DE GIOVANNI C; LOLLINI PL; LANZARDO S; FORNI G; SANGES R; CRISPI S; DE LUCA P; CALOGERO R; CAVALLO F.
File in questo prodotto:
File Dimensione Formato  
quaglino.et.al.2004.pdf

non disponibili

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 4.86 MB
Formato Adobe PDF
4.86 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/40076
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 72
  • ???jsp.display-item.citation.isi??? 67
social impact